anti-alpha CGRP antibody product blog
Tags: Antibody; Monoclonal Antibody; alpha CGRP; anti-alpha CGRP antibody;
The alpha CGRP n/a (Catalog #MBS837883) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The alpha CGRP antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s alpha CGRP can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the alpha CGRP n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the alpha CGRP antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Paraffin embedded rat tissue stained with alpha CGRP antibody diluted 1/400 in 1% BSA/PBS and incubated overnight)
Mouse monoclonal alpha CGRP antibody.
Biological Significance: alpha CGRP is produced in both peripheral and central neurons. It is a potent peptide vasodilator and can function in the transmission of pain. Cross-Reactivity: Human, Rat
Immunogen: alpha CGRP antibody was raised in Mouse using Synthetic human alpha-CGRP as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing alpha CGRP are readily searchable from our website. Different antibodies against the same target such as alpha CGRP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.